Columbia SkinCare unveils patent-pending photoprotection system
Columbia SkinCare says it has developed a patent-pending photoprotection system designed to go beyond conventional sunscreen by supporting the skin’s natural defense and repair mechanisms. The Bronxville, New York company says the technology could form the basis of a new product category and may also be available for licensing.
Why it matters: - Columbia SkinCare is positioning photoprotection as an active biological process, not just a UV filter. - The approach targets skin resilience, long-term skin health and visible aging linked to chronic sun exposure. - The company says the technology could support a new category of photoprotection products.
What happened: - Columbia SkinCare announced a patent-pending photoprotection system on July 2, 2026, in Bronxville, New York. - The system is designed to work with the skin’s biology rather than rely only on passive UV filtration. - CEO Steven Rosenfeld said the company is challenging the traditional “block, absorb, repeat” model of sun protection.
The details: - The proprietary system is designed to support the skin’s response to UV-induced stress. - It is intended to help maintain cellular turnover and desquamation. - It aims to reduce downstream effects linked to cumulative photodamage. - It is designed to enhance skin resilience under environmental exposure. - Preliminary internal evaluations indicate the approach may offer advantages over traditional sunscreen formulations. - Rosenfeld said the platform is meant to stabilize skin across molecular, cellular and microbial layers. - The company says the technology helps support resolution of DNA damage, reduce oxidative stress and maintain RNA integrity during UV exposure. - Columbia SkinCare says those mechanisms matter because they help prevent downstream cellular dysfunction and premature aging. - The company says the system reflects a broader scientific focus on preserving the skin’s natural ecosystem. - That approach combines skin biology, microbiome balance and cellular signaling.
Between the lines: - Columbia SkinCare is framing the technology as a shift from protection-only products to skin-support products. - The language around biological intelligence signals a bet that consumers and partners may value skincare that promises repair and adaptation, not just sunblock. - The licensing mention suggests the company may monetize the technology beyond its own product line.
What’s next: - Columbia SkinCare says the patent-pending technology will serve as the foundation for photoprotection products now under development. - The company is considering licensing opportunities for the technology. - More product details and commercial timing have not been disclosed.
The bottom line: - Columbia SkinCare is betting that the next wave of sun care will be built around preserving how skin functions, not just shielding it from UV rays. - More information: the company's announcement
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Tech Times of New York
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.